GE Healthcare Technologies Inc
NASDAQ:GEHC
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
58.75
93.48
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
GEHC
stock under the Base Case scenario is
88.06
USD.
Compared to the current market price of 78.1 USD,
GE Healthcare Technologies Inc
is
Undervalued by 11%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for GE Healthcare Technologies Inc.
Fundamental Analysis
GEHC Profitability Score
Profitability Due Diligence
Score
GEHC Solvency Score
Solvency Due Diligence
Score
Select up to 3 indicators:
Select up to 3 indicators:
GE HealthCare’s reliance on large-scale capital equipment sales may face headwinds if hospital budgets tighten, leading to slower revenue growth in its flagship imaging solutions segment. Extended sales cycles or delayed purchasing decisions could hurt topline momentum.
The company’s separation from the wider General Electric ecosystem could diminish the cost advantages and shared R&D benefits it once enjoyed, pressuring operating margins and impeding the pace of technological innovation.
Intense competition in imaging and diagnostics from established players like Siemens Healthineers and Philips challenges GE HealthCare’s market share, potentially forcing aggressive pricing to maintain customer loyalty and eroding profitability.
Strong demand for advanced diagnostic imaging and precision health solutions, driven by an aging global population and a rising burden of chronic diseases, underpins substantial long-term growth potential for GE HealthCare’s core product lines.
The company’s renewed focus on standalone strategy post-spin-off allows it to streamline operations, accelerate innovation in software-driven solutions, and invest any freed-up capital to bolster its digital healthcare portfolio, enhancing its competitive positioning.
GE HealthCare’s global footprint and existing customer relationships provide a stable sales pipeline. Its strong service network, tied to proprietary imaging hardware, creates recurring revenue streams through maintenance and upgrade cycles.
Balance Sheet Decomposition
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc
Free Cash Flow Analysis
GE Healthcare Technologies Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
GE Healthcare Technologies Inc
Wall St
Price Targets
GEHC Price Targets Summary
GE Healthcare Technologies Inc
According to Wall Street analysts, the average 1-year price target for
GEHC
is 93.55 USD
with a low forecast of 73.73 USD and a high forecast of 113.4 USD.
Dividends
Current shareholder yield for
GEHC is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
GEHC
stock under the Base Case scenario is
88.06
USD.
Compared to the current market price of 78.1 USD,
GE Healthcare Technologies Inc
is
Undervalued by 11%.